Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Johnson and Johnson
Medtronic
Express Scripts
Mallinckrodt

Last Updated: November 30, 2021

DrugPatentWatch Database Preview

Litigation Details for Noven Pharmaceuticals, Inc. v. Amneal Pharmaceuticals LLC (D. Del. 2018)


Email this page to a colleague

« Back to Dashboard

Small Molecule Drugs cited in Noven Pharmaceuticals, Inc. v. Amneal Pharmaceuticals LLC
The small molecule drug covered by the patents cited in this case is ⤷  Free Forever Trial .

Details for Noven Pharmaceuticals, Inc. v. Amneal Pharmaceuticals LLC (D. Del. 2018)

Date Filed Document No. Description Snippet Link To Document
2019-01-27 Dismissal of Counterclaim Pertaining to U.S. Patent No. 8,231,906. Signed by Judge Leonard P. Stark on 1/25…2018 11 September 2020 1:18-cv-00699 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2019-03-07 112 Opinion - Memorandum Opinion infringement of U.S. Patent Nos. 9,730,900 (the "' 900 Patent"), 9,724,310 (the '"…quot; 310 Patent"), and 9,833 ,419 (the '" 419 Patent") (collectively, "patents-in-suit…-suit" or "asserted patents"). (D.I. 83 at 3) The patents-in-suit relate "to transdermal…; It is a bedrock principle of patent law that the claims of a patent define the invention to which the…reading the entire patent." Id. at 1321 (internal quotation marks omitted). The patent "specification External link to document
2018-06-01 13 Patent/Trademark Report to Commissioner of Patents the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,841,716 . (Wilson, Samantha…2018 11 September 2020 1:18-cv-00699 Patent - Abbreviated New Drug Application(ANDA) None External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
McKesson
Harvard Business School
Johnson and Johnson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.